While lipid-based nanoparticles have been primarily utilized to prevent mRNA degradation and improve delivery to antigen-presenting cells, some have also been shown to activate TLR4 signaling and thereby increase anti-tumor vaccine efficacy in murine tumor models [178,179]. Here, TLR4 is linked to neoplasm.